Logo image of IBN

ICICI BANK LTD-SPON ADR (IBN) Stock Fundamental Analysis

NYSE:IBN - New York Stock Exchange, Inc. - US45104G1040 - ADR - Currency: USD

33.52  -0.06 (-0.18%)

Premarket: 33.35 -0.17 (-0.51%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IBN. IBN was compared to 395 industry peers in the Banks industry. There are concerns on the financial health of IBN while its profitability can be described as average. IBN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year IBN was profitable.
In the past year IBN had a positive cash flow from operations.
Each year in the past 5 years IBN has been profitable.
Of the past 5 years IBN 4 years had a positive operating cash flow.
IBN Yearly Net Income VS EBIT VS OCF VS FCFIBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B 1T 1.5T

1.2 Ratios

IBN has a better Return On Assets (1.93%) than 96.20% of its industry peers.
With an excellent Return On Equity value of 16.26%, IBN belongs to the best of the industry, outperforming 94.94% of the companies in the same industry.
Industry RankSector Rank
ROA 1.93%
ROE 16.26%
ROIC N/A
ROA(3y)1.85%
ROA(5y)1.63%
ROE(3y)16.47%
ROE(5y)14.97%
ROIC(3y)N/A
ROIC(5y)N/A
IBN Yearly ROA, ROE, ROICIBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

IBN has a Profit Margin (24.82%) which is comparable to the rest of the industry.
IBN's Profit Margin has improved in the last couple of years.
IBN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 24.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.78%
PM growth 5Y22.23%
GM growth 3YN/A
GM growth 5YN/A
IBN Yearly Profit, Operating, Gross MarginsIBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

IBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IBN has been increased compared to 1 year ago.
IBN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IBN has been reduced compared to a year ago.
IBN Yearly Shares OutstandingIBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
IBN Yearly Total Debt VS Total AssetsIBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T 20T 25T

2.2 Solvency

IBN has a debt to FCF ratio of 1.85. This is a very positive value and a sign of high solvency as it would only need 1.85 years to pay back of all of its debts.
IBN has a Debt to FCF ratio of 1.85. This is comparable to the rest of the industry: IBN outperforms 54.18% of its industry peers.
IBN has a Debt/Equity ratio of 0.70. This is a neutral value indicating IBN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.70, IBN is doing worse than 81.52% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for IBN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 1.85
Altman-Z N/A
ROIC/WACCN/A
WACC8.72%
IBN Yearly LT Debt VS Equity VS FCFIBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1T 2T 3T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IBN Yearly Current Assets VS Current LiabilitesIBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

More info and screens

7

3. Growth

3.1 Past

IBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.67%, which is quite good.
IBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 37.34% yearly.
IBN shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.94%.
The Revenue has been growing by 14.35% on average over the past years. This is quite good.
EPS 1Y (TTM)14.67%
EPS 3Y26.09%
EPS 5Y37.34%
EPS Q2Q%14.85%
Revenue 1Y (TTM)26.94%
Revenue growth 3Y20.88%
Revenue growth 5Y14.35%
Sales Q2Q%196.97%

3.2 Future

IBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.12% yearly.
IBN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.15% yearly.
EPS Next Y8.66%
EPS Next 2Y11.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11%
Revenue Next 2Y12.77%
Revenue Next 3Y15.15%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IBN Yearly Revenue VS EstimatesIBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500B 1T 1.5T 2T
IBN Yearly EPS VS EstimatesIBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.95, which indicates a rather expensive current valuation of IBN.
79.75% of the companies in the same industry are cheaper than IBN, based on the Price/Earnings ratio.
IBN is valuated rather cheaply when we compare the Price/Earnings ratio to 24.95, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.69 indicates a rather expensive valuation of IBN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBN indicates a slightly more expensive valuation: IBN is more expensive than 77.97% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.99. IBN is around the same levels.
Industry RankSector Rank
PE 19.95
Fwd PE 19.69
IBN Price Earnings VS Forward Price EarningsIBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

IBN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBN is cheaper than 76.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.64
EV/EBITDA N/A
IBN Per share dataIBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.3
PEG (5Y)0.53
EPS Next 2Y11.12%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.70%, IBN is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.42, IBN's dividend is way lower than its industry peers. On top of this 85.57% of the companies listed in the same industry pay a better dividend than IBN!
Compared to an average S&P500 Dividend Yield of 2.41, IBN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

On average, the dividend of IBN grows each year by 48.58%, which is quite nice.
IBN has paid a dividend for at least 10 years, which is a reliable track record.
IBN has decreased its dividend recently.
Dividend Growth(5Y)48.58%
Div Incr Years1
Div Non Decr Years1
IBN Yearly Dividends per shareIBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 50 100 150 200

5.3 Sustainability

13.80% of the earnings are spent on dividend by IBN. This is a low number and sustainable payout ratio.
The dividend of IBN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP13.8%
EPS Next 2Y11.12%
EPS Next 3YN/A
IBN Yearly Income VS Free CF VS DividendIBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B 1T 1.5T
IBN Dividend Payout.IBN Dividend Payout, showing the Payout Ratio.IBN Dividend Payout.PayoutRetained Earnings

More info and screens

ICICI BANK LTD-SPON ADR

NYSE:IBN (5/13/2025, 8:04:00 PM)

Premarket: 33.35 -0.17 (-0.51%)

33.52

-0.06 (-0.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-19 2025-04-19/amc
Earnings (Next)07-25 2025-07-25
Inst Owners54.63%
Inst Owner Change0.93%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.46B
Analysts87.44
Price Target39.21 (16.97%)
Short Float %0.71%
Short Ratio4.17
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly Dividend0.23
Dividend Growth(5Y)48.58%
DP13.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)79.67%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)161.52%
Revenue beat(4)1
Avg Revenue beat(4)38.41%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)161.52%
Revenue beat(8)3
Avg Revenue beat(8)23.51%
Revenue beat(12)7
Avg Revenue beat(12)56.74%
Revenue beat(16)11
Avg Revenue beat(16)78.29%
PT rev (1m)9.55%
PT rev (3m)11.58%
EPS NQ rev (1m)2.1%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)-0.3%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.76%
Revenue NY rev (3m)-4.72%
Valuation
Industry RankSector Rank
PE 19.95
Fwd PE 19.69
P/S 4.96
P/FCF 8.64
P/OCF 8.3
P/B 3.25
P/tB 3.34
EV/EBITDA N/A
EPS(TTM)1.68
EY5.01%
EPS(NY)1.7
Fwd EY5.08%
FCF(TTM)3.88
FCFY11.58%
OCF(TTM)4.04
OCFY12.05%
SpS6.76
BVpS10.32
TBVpS10.04
PEG (NY)2.3
PEG (5Y)0.53
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 16.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.82%
GM N/A
FCFM 57.42%
ROA(3y)1.85%
ROA(5y)1.63%
ROE(3y)16.47%
ROE(5y)14.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.78%
PM growth 5Y22.23%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 1.85
Debt/EBITDA N/A
Cap/Depr 177.3%
Cap/Sales 2.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 231.31%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)170.52%
Cap/Depr(5y)150.4%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.67%
EPS 3Y26.09%
EPS 5Y37.34%
EPS Q2Q%14.85%
EPS Next Y8.66%
EPS Next 2Y11.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.94%
Revenue growth 3Y20.88%
Revenue growth 5Y14.35%
Sales Q2Q%196.97%
Revenue Next Year11%
Revenue Next 2Y12.77%
Revenue Next 3Y15.15%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.54%
FCF growth 3Y28.45%
FCF growth 5Y8.72%
OCF growth 1Y-22.3%
OCF growth 3Y28.74%
OCF growth 5Y9.07%